Who is sponsoring NCT03219541?

NCT03219541 is sponsored by NYU Langone Health.

What drugs are being tested in NCT03219541?

Interventions in NCT03219541: Interventional Automated mobile phone text, Control Automated mobile phone text.

Is NCT03219541 still recruiting?

NCT03219541 is currently completed. Last updated 17 April 2020.

Last reviewed 2020-04-17 · How we verify

NCT03219541

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Feasibility and Acceptability of a Text Messaging Intervention to Increase Smoking Cessation in Vietnam

Completed NA Last updated 17 April 2020

What this trial tests

NA trial testing Interventional Automated mobile phone text in Smoking in 190 participants. Completed in 13 March 2019.

Timeline

5 February 2018

Primary endpoint
13 March 2019

13 March 2019

Quick facts

Lead sponsor	NYU Langone Health
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	190
Start date	5 February 2018
Primary completion	13 March 2019
Estimated completion	13 March 2019
Sites	1 location across United States

Drugs / interventions tested

Interventional Automated mobile phone text
Control Automated mobile phone text

Conditions studied

Smoking — all drugs for Smoking →

Sponsor

NYU Langone Health — full company profile →

Who can join

21 and older, any sex, with Smoking. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to develop and then test the feasibility, acceptability, and preliminary effect of a bidirectional text message smoking cessation intervention among Vietnamese smokers in Hanoi, Vietnam. The specific aim are: 1) To develop a smoking cessation text message library among Vietnamese smokers; 2) To evaluate message preferences, and the feasibility and acceptability of the bidirectional text message smoking cessation intervention; and 3) To assess the preliminary effect of a bidirectional mobile phone text message intervention on biochemically validated smoking abstinence.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Adaptation and Assessment of a Text Messaging Smoking Cessation Intervention in Vietnam: Pilot Randomized Controlled Trial.
Jiang N, Nguyen N, Siman N, Cleland CM, et al · · 2021 · cited 14× · PMID 34623318 · DOI 10.2196/27478

Verify or expand the search:

Other recruiting trials for Smoking

Currently open trials in the same condition.

NCT07488741 — Comparison of the Effects of Different Chest Techniques on University Students With Smoking Addiction · NA · recruiting
NCT07443631 — Assessment of HPHC Exposure in Smokers Switching to THS/TP18 With Different Device Variants · NA · recruiting
NCT07132814 — Abuse Liability for Five Modern Oral Nicotine Products · NA · recruiting
NCT06966258 — Inspire HER: Inspiring the Heart and Emotions for Radical Health · NA · recruiting
NCT06713603 — Technology Assisted Motivational Interviewing · NA · recruiting

Other NYU Langone Health trials

Trials by the same sponsor.

NCT07214519 — Permanent Supportive Housing Overdose Prevention-2 Study · NA · not yet recruiting
NCT05558267 — Potassium Containing Salt-Substitute in Hemodialysis-Dependent End Stage Kidney Disease · NA · not yet recruiting
NCT06637852 — Sexual and Urinary Function Improvement for Cancer Survivors · NA · not yet recruiting
NCT06236087 — Overdose Prevention Centers and Behavioral Health · not yet recruiting
NCT06462027 — Packed Red Blood Cell Transfusion During Cardiac Arrest · Phase 1 · suspended

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03219541 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by NYU Langone Health
Last refreshed: 17 April 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03219541.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing